CVS Health Corp (N:CVS)

Business Focus: Healthcare Facilities & Services

Sector:  Healthcare Industry:  Healthcare Facilities & Services
 
See Regulatory Filings on SEC
Company Contact
Address: 1 Cvs Dr
WOONSOCKET RI 02895-6146
Tel: N/A
Website: https://www.cvshealth.com
IR: See website
<
Key People
David Wyatt Dorman
Independent Chairman of the Board
James D. Clark
Senior Vice President, Chief Accounting Officer, Controller
Larry J. Merlo
President, Chief Executive Officer, Director
Eva C. Boratto
Chief Financial Officer, Executive Vice President
Kevin Hourican
President of CVS Pharmacy
Derica W. Rice
President - CVS Caremark
Jonathan C. Roberts
Chief Operating Officer, Executive Vice President
Lisa G. Bisaccia
Chief Human Resource Officer, Executive Vice President
Thomas M. Moriarty
Executive Vice President, General Counsel, Chief Policy and External Affairs Officer
Troyen A. Brennan
Executive Vice President, Chief Medical Officer
   
Business Overview
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc. (Omnicare) and Omnicare's long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings. It operates through three segments: Pharmacy Services, Retail/LTC and Corporate. The Pharmacy Services Segment provides a range of pharmacy benefit management (PBM) solutions to its clients. As of December 31, 2016, the Retail/LTC Segment included 9,709 retail locations (of which 7,980 were its stores that operated a pharmacy and 1,674 were its pharmacies located within Target Corporation (Target) stores), its online retail pharmacy Websites, CVS.com, Navarro.com and Onofre.com.br, 38 onsite pharmacy stores, its long-term care pharmacy operations and its retail healthcare clinics.
Financial Overview
For the three months ended 31 March 2019, CVS Health Corp revenues increased 35% to $61.65B. Net income applicable to common stockholders increased 42% to $1.42B. Revenues reflect Pharmacy Services Segment increase of 4% to $33.56B, Retail Pharmacy Segment increase of 3% to $21.12B. Net income benefited from Pharmacy Services Segment income increase of 12% to $850M, Intersegment Elimination loss decrease of 2% to $172M.
Employees: 295,000 as of Dec 31, 2018
Reporting Currency: U.S. Dollars
Enterprise value: $135,407M as of Mar 31, 2019
Annual revenue (TTM): $210,532M as of Mar 31, 2019
EBITDA (TTM): $14,099M as of Mar 31, 2019
Net annual income (TTM): -$275.00M as of Mar 31, 2019
Free cash flow (TTM): $4,008M as of Mar 31, 2019
Net Debt Last Fiscal Year: $66,464M as of Mar 31, 2019
Shares outstanding: 1,299,092,100 as of Apr 23, 2019
Index Membership: S&P 500
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization